Motivational Interviewing (MI) to Reduce Khat Use

Khat Use Disorder Clinical Trial

— MIkhat  

Official title:

Evaluation of Motivational Interviewing (MI) to Reduce Khat Use Among Somali Refugees in Kenya

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02253589
• Other study ID #: 01DG13020
• Status: Completed
• Phase: N/A
• First received: September 24, 2014
• Last updated: May 10, 2017
• Start date: October 2014
• Est. completion date: December 2015

Study information

• Verified date: May 2017
• Source: University of Konstanz
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Healthy khat user with the intention to reduce or stop khat use will be randomly assigned to a one-session brief intervention or waiting list. Reductions in khat use will be measured from pre- to post-assessment which will be one month apart. After one month, the waiting list will receive the same intervention.

Description:

The leaves of the khat tree are traditionally chewed in some African and Arab countries. They contain the mild central stimulant cathinone. In recent years, the production, trade and use has dramatically increased and excessive patterns of use as well as a specific dependence syndrome have been described. So far, no experiences exist in psychological treatment of khat addiction.

In this study, we use a brief motivational intervention based on the WHO's ASSIST-linked Brief Intervention and Motivational Interviewing to support users who have the intention to reduce or stop their khat use. Khat users will be recruited in the community. Trained local staff will assess participant's khat and other substance use at study entry and one month later. Users will be assigned randomly to intervention or waiting list control groups. The intervention group will receive a single 20-minute brief intervention. The waiting list will receive the same intervention after the second assessment. After two months, a final assessment will be made in both groups.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: December 2015
• Est. primary completion date: December 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Healthy individuals

Exclusion Criteria:

Severe psychiatric disorders

Related Conditions & MeSH terms

• Khat Use Disorder

Intervention

Behavioral:
• modified ASSIST-linked Brief Intervention
Trained counsellors support participant's motivation to reduce or stop khat use in a 20 minute counselling session.

Locations

Country	Name	City	State
Kenya	Tawakal Clinic	Nairobi

Sponsors (2)

Lead Sponsor	Collaborator
University of Konstanz	Africa Mental Health Foundation

Country where clinical trial is conducted

Kenya, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time-Line-Follow-Back: Self-reported days with khat use and amount of khat use	Participants report in a calender for each day of the past month whether they used khat and how much of it.	one month
Secondary	Time-Line-Follow-Back: other substance use	Participants report for each day of the past month whether they used other substances of abuse, i.e. alcohol, illegal drugs	One month